Senior Manager, Consolidation; Maternity Cover

Lead the Account-to-Report team and co-lead the Vifor Consolidation function, ensuring accurate, timely and compliant financial reporting across a global portfolio of legal entities. The role is responsible for statutory reporting, external audit coordination, group consolidation activities, financial controls, process standardisation and continuous improvement initiatives. It acts as a key business partner to Group Reporting, Tax, Treasury, Finance Business Partners and external auditors.

• Co-lead global consolidation activities for Vifor entities, ensuring accurate and timely reporting under IFRS and Group reporting requirements across HFM/Hyperion and Finance Core.
• Reconcile balance sheet and cash flow consolidation results between HFM and Finance Core, investigating and resolving variances.
• Support the Financial Planning and Analytics team to review financial results.
• Own and oversee month-end, quarter-end, half-year and year-end close activities.
• Ensure completeness and accuracy of financial information submitted to Group Reporting and other corporate stakeholders.
• Co-lead consolidated balance sheet planning, ensuring data is consistent across relevant systems.
• Support strategic finance transformation projects, including the migration of Vifor to Behring SAP in 2027 through Project UNIFY, the transition from HFM/Hyperion to Finance Core, and the adoption of the new planning system through Project Spark in 2026.

• Lead the Account-to-Report team in the preparation, review and filing of statutory financial statements.
• Oversee and provide guidance on technical accounting assessments and key accounting judgements, including impairment reviews, provisions and complex accounting matters.
• Ensure compliance with local regulatory requirements and evolving accounting standards, supported by external service providers where applicable.

• Lead, coach and develop a team of accounting professionals, fostering a high-performance and continuous improvement culture.
• Manage performance, objective setting, succession planning and development activities for direct reports, and provide guidance to indirect reports.
• Support team capability building, including digital upskilling, automation and adoption of new technologies.
• Allocate resources effectively to ensure delivery of key reporting, audit and project deadlines.

• Act as a key finance partner to Tax, Treasury, Group Reporting, Shared Services and senior finance leadership.
• Provide clear, practical insight on consolidation, statutory reporting and accounting matters to support effective decision-making.
• Build strong relationships with internal and external stakeholders to support timely resolution of reporting, audit and compliance matters.

• Maintain a strong internal control environment across the Vifor Account-to-Report and consolidation processes and support remediation of identified control weaknesses and process risks.
• Drive compliance with CSL accounting policies, IFRS requirements and applicable control frameworks.

• Bachelor's degree in Accounting, Finance or related discipline.
• ACA, ACCA, CPA or equivalent professional accounting qualification required.
• 7+ years' experience in financial accounting, consolidation, statutory reporting and audit.
• 3+ years of proven experience leading finance teams and managing complex stakeholder relationships.
• Experience with consolidation systems preferred (experience working with SAP, HFM/Hyperion desirable).
• Strong analytical, problem-solving and project management capabilities.
• Demonstrated success in finance transformation, process improvement and implementation of financial controls.

This role requires hybrid working from the Liverpool office 3 days per week

This role is also available to internal candidates as a secondment opportunity.

CSL Seqirus CSL Seqirus is part of CSL. As one of the largest influenza vaccine providers in the world, CSL Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness. With state-of-the-art production facilities in the U.S., the U.K. and Australia, CSL Seqirus utilizes egg, cell and adjuvant technologies to offer a broad portfolio of differentiated influenza vaccines in more than 20 countries around the world.

To learn more…